A citation-based method for searching scientific literature

Chunling Hu, Steven N Hart, Eric C Polley, Rohan Gnanaolivu, Hermela Shimelis, Kun Y Lee, Jenna Lilyquist, Jie Na, Raymond Moore, Samuel O Antwi, William R Bamlet, Kari G Chaffee, John DiCarlo, Zhong Wu, Raed Samara, Pashtoon M Kasi, Robert R McWilliams, Gloria M Petersen, Fergus J Couch. JAMA 2018
Times Cited: 159







List of co-cited articles
819 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
5

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
5

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
5

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
5

The epidemiology of pancreatitis and pancreatic cancer.
Dhiraj Yadav, Albert B Lowenfels. Gastroenterology 2013
893
5

Prospective risk of cancer in CDKN2A germline mutation carriers.
A M Goldstein, J P Struewing, M C Fraser, M W Smith, M A Tucker. J Med Genet 2004
48
10

High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.
Aimee L Lucas, Reena Shakya, Marla D Lipsyc, Elana B Mitchel, Sheila Kumar, Caroline Hwang, Liyong Deng, Catherine Devoe, John A Chabot, Matthias Szabolcs,[...]. Clin Cancer Res 2013
48
10

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, Karen Ng, Eugenia Flores Figueroa, Grainne M O'Kane, Ashton A Connor, Robert E Denroche, Robert C Grant, Jessica McLeod,[...]. Nat Genet 2020
83
6

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
G Lal, G Liu, B Schmocker, P Kaurah, H Ozcelik, S A Narod, M Redston, S Gallinger. Cancer Res 2000
169
5

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
717
5

Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Johann de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Oliver Sartor, Neeraj Agarwal, David Olmos,[...]. N Engl J Med 2020
291
5

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
Marcia Irene Canto, Michael Goggins, Charles J Yeo, Constance Griffin, Jennifer E Axilbund, Kieran Brune, Syed Z Ali, Sanjay Jagannath, Gloria M Petersen, Elliot K Fishman,[...]. Clin Gastroenterol Hepatol 2004
322
4

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
Jenna Lilyquist, Holly LaDuca, Eric Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N Hart, Jill S Dolinsky, Fergus J Couch, David E Goldgar. Gynecol Oncol 2017
50
8

Inherited DNA-Repair Defects in Colorectal Cancer.
Saud H AlDubayan, Marios Giannakis, Nathanael D Moore, G Celine Han, Brendan Reardon, Tsuyoshi Hamada, Xinmeng Jasmine Mu, Reiko Nishihara, Zhirong Qian, Li Liu,[...]. Am J Hum Genet 2018
44
9

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.
C M Phelan, J Iqbal, H T Lynch, J Lubinski, J Gronwald, P Moller, P Ghadirian, W D Foulkes, S Armel, A Eisen,[...]. Br J Cancer 2014
76
5

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
317
4


Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
333
4

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
174
4

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
161
4

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
438
4

Altered exocrine function can drive adipose wasting in early pancreatic cancer.
Laura V Danai, Ana Babic, Michael H Rosenthal, Emily A Dennstedt, Alexander Muir, Evan C Lien, Jared R Mayers, Karen Tai, Allison N Lau, Paul Jones-Sali,[...]. Nature 2018
57
7

Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Raghuwansh P Sah, Ayush Sharma, Sajan Nagpal, Sri Harsha Patlolla, Anil Sharma, Harika Kandlakunta, Vincent Anani, Ramcharan Singh Angom, Amrit K Kamboj, Nazir Ahmed,[...]. Gastroenterology 2019
17
23

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.
Jared R Mayers, Chen Wu, Clary B Clish, Peter Kraft, Margaret E Torrence, Brian P Fiske, Chen Yuan, Ying Bao, Mary K Townsend, Shelley S Tworoger,[...]. Nat Med 2014
307
4

BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
Aimee L Lucas, Laura E Frado, Caroline Hwang, Sheila Kumar, Lauren G Khanna, Elana J Levinson, John A Chabot, Wendy K Chung, Harold Frucht. Cancer 2014
36
11

Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Linda C Chu, Seyoun Park, Satomi Kawamoto, Daniel F Fouladi, Shahab Shayesteh, Eva S Zinreich, Jefferson S Graves, Karen M Horton, Ralph H Hruban, Alan L Yuille,[...]. AJR Am J Roentgenol 2019
39
10

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
968
4

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
4

Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer.
Tomohiro Kondo, Masashi Kanai, Tadayuki Kou, Tomohiro Sakuma, Hiroaki Mochizuki, Mayumi Kamada, Masahiko Nakatsui, Norimitsu Uza, Yuzo Kodama, Toshihiko Masui,[...]. Oncotarget 2018
33
12


Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.
Michael J Pishvaian, Robert J Bender, David Halverson, Lola Rahib, Andrew E Hendifar, Sameh Mikhail, Vincent Chung, Vincent J Picozzi, Davendra Sohal, Edik M Blais,[...]. Clin Cancer Res 2018
62
6

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Conan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, Katrin P Guillen, Mona Foth, Amanda Truong, Sophia S Schuman, Jill E Shea, Michael T Seipp, Jeffrey T Yap,[...]. Nat Med 2019
193
4

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
4

Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
Tomas DaVee, Emmanuel Coronel, Charilaos Papafragkakis, Sayam Thaiudom, Gandhi Lanke, Raja C Chakinala, Graciela M Nogueras González, Manoop S Bhutani, William A Ross, Brian R Weston,[...]. Gastrointest Endosc 2018
21
19

Anticipation in familial pancreatic cancer.
C D McFaul, W Greenhalf, J Earl, N Howes, J P Neoptolemos, R Kress, M Sina-Frey, H Rieder, S Hahn, D K Bartsch. Gut 2006
89
4

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
111
4

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
329
4

Hypermutation In Pancreatic Cancer.
Jeremy L Humphris, Ann-Marie Patch, Katia Nones, Peter J Bailey, Amber L Johns, Skye McKay, David K Chang, David K Miller, Marina Pajic, Karin S Kassahn,[...]. Gastroenterology 2017
106
4

Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series.
Vinciane Rebours, Marie-Christine Boutron-Ruault, Matthieu Schnee, Claude Férec, Frédérique Maire, Pascal Hammel, Philippe Ruszniewski, Philippe Lévy. Am J Gastroenterol 2008
154
4

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
248
4

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.
F M Giardiello, G J Offerhaus, D H Lee, A J Krush, A C Tersmette, S V Booker, N C Kelley, S R Hamilton. Gut 1993
239
4

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.
A B Lowenfels, P Maisonneuve, G Cavallini, R W Ammann, P G Lankisch, J R Andersen, E P Dimagno, A Andrén-Sandberg, L Domellöf. N Engl J Med 1993
4

High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations.
M G F van Lier, A Wagner, E M H Mathus-Vliegen, E J Kuipers, E W Steyerberg, M E van Leerdam. Am J Gastroenterol 2010
259
4

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.
Ilir Agalliu, Robert Gern, Suzanne Leanza, Robert D Burk. Clin Cancer Res 2009
82
4


CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations.
Robert R McWilliams, Eric D Wieben, Kari G Chaffee, Samuel O Antwi, Leon Raskin, Olufunmilayo I Olopade, Donghui Li, W Edward Highsmith, Gerardo Colon-Otero, Lauren G Khanna,[...]. Cancer Epidemiol Biomarkers Prev 2018
9
44

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
240
4

A multimodality test to guide the management of patients with a pancreatic cyst.
Simeon Springer, David L Masica, Marco Dal Molin, Christopher Douville, Christopher J Thoburn, Bahman Afsari, Lu Li, Joshua D Cohen, Elizabeth Thompson, Peter J Allen,[...]. Sci Transl Med 2019
45
8


Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Aatur D Singhi, Kevin McGrath, Randall E Brand, Asif Khalid, Herbert J Zeh, Jennifer S Chennat, Kenneth E Fasanella, Georgios I Papachristou, Adam Slivka, David L Bartlett,[...]. Gut 2018
125
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.